Multicenter Automatic Defibrillator Implantation Trial- Chemotherapy Induced Cardiomyopathy
A study for patients with impaired heart function using a cardiac device to pace the heart more efficiently
Sponsor: University of Rochester
Enrolling: Male and Female Patients
IRB Number: AAAN4005
U.S. Govt. ID: NCT02164721
Contact: Gregg Rosner MD: 1 212 342 3820 / gfr2107@cumc.columbia.edu
Additional Study Information: The purpose of this trial is to determine if people with impaired heart function, that may have been induced with chemotherapeutic drugs and/or radiation, will have improved heart function with a cardiac device that can pace the heart more efficiently using cardiac resynchronization therapy.
This study is closed
Investigator
Gregg Rosner, MD
Do You Qualify?
Do you have a currently implanted pacemaker or implantable cardioverter defibrillator (ICD) device? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Gregg Rosner MD
gfr2107@cumc.columbia.edu
1 212 342 3820
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE